Stonepine Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Buy |
604,066
+13,324
| +2% | +$101K | 4.48% | 7 |
|
|
2025
Q1 | $3.26M | Buy |
590,742
+258,842
| +78% | +$1.43M | 3.17% | 9 |
|
|
2024
Q4 | $1.91M | Buy |
+331,900
| New | +$1.91M | 1.54% | 20 |
|
|
2022
Q2 | – | Sell |
-119,972
| Closed | -$8.54M | – | 27 |
|
|
2022
Q1 | $8.54M | Buy |
+119,972
| New | +$8.54M | 3.54% | 11 |
|
|
2019
Q4 | – | Sell |
-129,867
| Closed | -$7.8M | – | 26 |
|
|
2019
Q3 | $7.8M | Buy |
129,867
+64,383
| +98% | +$3.87M | 7.57% | 4 |
|
|
2019
Q2 | $5.53M | Buy |
65,484
+4,644
| +8% | +$392K | 3.8% | 10 |
|
|
2019
Q1 | $5.81M | Buy |
+60,840
| New | +$5.81M | 3.34% | 12 |
|
|
2018
Q1 | – | Sell |
-218,434
| Closed | -$12.8M | – | 33 |
|
|
2017
Q4 | $12.8M | Sell |
218,434
-171,566
| -44% | -$10.1M | 7.68% | 5 |
|
|
2017
Q3 | $18.3M | Sell |
390,000
-102,265
| -21% | -$4.79M | 10.76% | 2 |
|
|
2017
Q2 | $17.7M | Buy |
492,265
+307,166
| +166% | +$11.1M | 9.56% | 2 |
|
|
2017
Q1 | $5.7M | Sell |
185,099
-46,814
| -20% | -$1.44M | 3.21% | 11 |
|
|
2016
Q4 | $7.77M | Buy |
+231,913
| New | +$7.77M | 4.63% | 9 |
|
|
2016
Q1 | – | Sell |
-71,147
| Closed | -$2.35M | – | 20 |
|
|
2015
Q4 | $2.35M | Buy |
+71,147
| New | +$2.35M | 2.75% | 10 |
|